01Core principlesThe concepts and mechanisms needed to understand the subject.
The Rutherford scheme is a bedside description of acute limb viability. It combines the extent of sensory loss, degree of motor deficit and presence of arterial and venous Doppler signals. It is not a score obtained by adding the six Ps, and it does not depend on a single ABPI, CK value or angiographic appearance. Its value is that each category implies how urgently flow must be restored and whether salvage remains biologically plausible.
Category I is viable: there is no sensory loss or weakness and both arterial and venous Doppler signals are audible. Category II is threatened but salvageable. IIa is marginally threatened, with no sensory loss or minimal toe numbness, no motor deficit, no arterial signal and a venous signal. IIb is immediately threatened, with sensory loss beyond the toes and rest pain, mild to moderate weakness, no arterial signal and a venous signal. Category III is irreversible, with profound anaesthesia, paralysis or rigor, absent arterial and venous signals, absent capillary refill and major tissue injury.
Clinical decisions follow the category but still require experienced judgement. A viable or IIa limb can generally undergo rapid imaging to plan treatment; IIb requires emergency revascularisation and imaging only if it does not delay that treatment. Reperfusing confirmed Rutherford III tissue is usually inappropriate because permanent nerve and major tissue damage are inevitable and necrotic muscle can release potassium, acid and myoglobin. The classification must be repeated because deterioration can occur within hours.
Key points
- Rutherford I has no sensory or motor loss with audible arterial and venous signals; IIa has none or toe-only sensory loss, no weakness, absent arterial but present venous signal.
- Rutherford IIb has sensory loss beyond the toes or rest pain plus mild to moderate weakness: contact vascular surgery immediately, anticoagulate unless contraindicated, and perform emergency revascularisation without imaging delay.
- Rutherford III has profound anaesthesia, profound paralysis or rigor, absent arterial and venous signals and usually fixed skin change: seek senior confirmation, then primary amputation or palliation rather than reperfusion.
- Motor deficit carries greater threat than paraesthesia alone because ischaemia has progressed to motor nerve and muscle dysfunction.
- The category is dynamic, so repeat the exact neurological and Doppler examination through every delay and transfer.
- Capillary refill and biomarkers support classification but do not overrule the sensory, motor and Doppler pattern.
- A currently viable Rutherford I limb still needs urgent vascular assessment and revascularisation planning.
- Rutherford IIa is salvageable with prompt treatment and can usually undergo rapid imaging if that does not create harmful delay.
02Mechanisms and patternsImportant relationships and how to distinguish them.
No sensory loss and normal motor function occur with audible arterial and venous Doppler signals; the limb is not immediately threatened but still needs urgent assessment.
Sensation is normal or minimally reduced at the toes, motor power is normal, arterial signal is absent and venous signal remains audible; prompt treatment can salvage the limb.
Sensory loss extends beyond the toes with rest pain and mild to moderate weakness; absent arterial but preserved venous signal accompanies an immediately threatened salvageable limb.
Profound anaesthesia and paralysis or rigor occur with absent arterial and venous signals, absent refill and established tissue injury, making meaningful salvage unlikely.
Map and time the boundary of light-touch loss because extension from toes into the forefoot or more proximally can convert IIa to IIb.
Test active toe and ankle movement repeatedly; any new ischaemic weakness is a decisive escalation feature even before complete paralysis develops.
Early pallor or mottling may blanch, whereas fixed non-blanching mottling, cool rigid muscle and loss of refill support irreversible tissue damage.
03Interpreting evidenceInformation, measurements and their limitations.
Consider the information, its meaning and its limitations before deciding what follows.
- 01
Serial sensory examination - Why
- Define the distribution and progression of ischaemic nerve dysfunction.
- Interpretation and limitations
- No loss supports I; toe-only loss fits IIa; loss beyond toes supports IIb; profound anaesthesia supports III. Pain and analgesia can confound cooperation, so record method and limitations.
- 02
Serial active motor examination - Why
- Detect muscle and motor-nerve dysfunction that establishes immediate limb threat.
- Interpretation and limitations
- Normal power is compatible with I or IIa, mild to moderate weakness defines IIb, and profound paralysis or rigor supports III. Compare toes and ankle with the opposite limb.
- 03
Handheld arterial and venous Doppler - Why
- Provide bedside haemodynamic signals that complement the neurological classification.
- Interpretation and limitations
- Both signals are generally present in I; absent arterial with present venous signal fits II; absence of both alongside profound neurological loss supports III. Doppler never substitutes for motor testing.
- 04
Capillary refill and skin assessment - Why
- Add visible evidence of microcirculatory failure and tissue injury.
- Interpretation and limitations
- Preserved refill favours viability, slow or absent refill accompanies threat, and fixed mottling with absent refill supports irreversibility. Shock and ambient temperature reduce specificity.
- 05
Creatine kinase, potassium and acid-base status - Why
- Estimate muscle injury and systemic risk around possible reperfusion.
- Interpretation and limitations
- Major CK elevation, hyperkalaemia and acidosis increase concern for advanced injury, but normal early biomarkers do not downgrade clinical IIb findings or exclude developing necrosis.
- 06
CTA, duplex or angiography - Why
- Define anatomy after clinical viability has established the safe imaging window.
- Interpretation and limitations
- Imaging guides treatment in I and IIa and may rapidly guide IIb if it causes no delay. It describes anatomy, not the biological reversibility established at the bedside.
04Applied reasoningWorked examples connecting principles to decisions.
01Worked case: toe numbness becomes weaknessReclassify a changing limbA patient initially has toe-only numbness and no weakness, then develops reduced ankle dorsiflexion while awaiting CTA.+
- 1Initial inputs are absent arterial but preserved venous Doppler signal, sensory loss confined to toes and normal active toe and ankle movement, supporting Rutherford IIa.
- 2Repeat examination detects sensory extension beyond the toes and new dorsiflexion weakness, so the reasoning changes the category from marginal IIa to immediate IIb threat.
- 3Tell the vascular clinician immediately, continue UFH when safe and redirect the pathway toward emergency revascularisation rather than waiting for delayed imaging.
- 4Verify the change by documenting time, exact muscle movements, sensory boundary and Doppler sites while monitoring physiology through transfer.
- 5After reperfusion, confirm haemodynamic and neurological response and monitor potassium, kidney function and compartments.
02Viable or marginal routeImage quickly and preserve surveillanceThere is no motor deficit and sensory function is normal or reduced only at the toes.+
- 1Maintain urgent vascular involvement and anticoagulation when safe because I and IIa can still progress.
- 2Obtain rapid CTA, duplex or angiography chosen for anatomy and local expertise without unnecessary transfers or serial gatekeeping tests.
- 3Repeat sensory, motor and Doppler findings until definitive treatment and communicate any deterioration immediately.
03Immediately threatened routeMove directly toward reperfusionSensation is lost beyond the toes or mild to moderate ischaemic weakness is present.+
- 1Treat the limb as Rutherford IIb and establish direct vascular control of imaging, transfer and theatre priorities.
- 2Perform only imaging that will immediately guide intervention without postponing emergency revascularisation.
- 3Continue analgesia, UFH when not contraindicated and preparation for open, endovascular or hybrid treatment.
- 4Monitor for progression to profound paralysis, acidosis, hyperkalaemia and systemic instability.
04Irreversible routeConfirm and avoid futile reperfusionProfound anaesthesia and paralysis or rigor coexist with absent arterial and venous signals and fixed tissue change.+
- 1Request immediate senior vascular confirmation and exclude confounding sedation, neuropathy, shock or technical Doppler failure.
- 2When Rutherford III is confirmed, avoid attempted limb reperfusion because tissue and nerve recovery is not expected and systemic harm may follow.
- 3Plan primary amputation or comfort-focused care with appropriate resuscitation, analgesia and multidisciplinary discussion.
05Relevant medicines and safetySpecific regimens and precautions where medicines are relevant.
Unfractionated heparin
For acute peripheral arterial occlusion, the UK product document gives 5,000 IU intravenously then 1,000–2,000 IU/hour by continuous infusion, adjusted using APTT measured from 4–6 hours after initiation.Avoid with active significant bleeding or current or previous immune heparin-induced thrombocytopenia and urgently review critical-site surgery or major trauma. Use the local preparation and UFH monitoring nomogram; obtain baseline platelets and coagulation without delaying vascular action, and consider reduced dosing or closer monitoring in older adults and advanced renal or hepatic disease.
06Checking understandingVerify the reasoning, revisit uncertainties and apply feedback.
- Repeat the full Rutherford inputs, not merely the category label: sensory boundary, named muscle movements, arterial signals and venous signals.
- During transfer or imaging, immediately report new weakness, spreading numbness, loss of venous Doppler sound or fixed skin change.
- Monitor UFH with the local APTT or anti-Xa nomogram and check haemoglobin, platelets and clinical bleeding.
- Trend ECG, potassium, pH, creatinine, CK and urine output when advanced ischaemia or reperfusion injury is possible.
- After revascularisation, confirm restored perfusion and observe for recurrent occlusion and compartment syndrome.
- For Rutherford III managed by amputation or palliation, continue analgesia, resuscitation and explicit goals-of-care communication.
07Special situationsVariants, exceptions and circumstances that change the usual approach.
Rutherford is a trajectory
A category records one examination at one time; it must change when sensory or motor findings change rather than becoming a fixed diagnosis.
Motor deficit dominates urgency
Mild weakness already indicates IIb immediate threat; waiting for complete paralysis sacrifices salvage time and risks irreversible injury.
Venous signal separates extremes
Preserved venous Doppler flow is typical in threatened II limbs, while loss of venous and arterial signals with profound neurology supports category III.
Biomarkers are supplementary
CK and myoglobin rise with muscle injury, but timing, chronic collateralisation and muscle mass limit their ability to classify early viability.
The scheme guides delay
The practical distinction between IIa and IIb is whether rapid imaging can safely precede treatment or emergency reperfusion must dominate the sequence.
Pain is not enough
Severe pain occurs across viable and threatened categories, while late irreversible tissue may become less painful as profound anaesthesia develops.
08Common pitfallsFrequent interpretation and management errors.
- 01
Calling toe-only paraesthesia IIb despite entirely normal motor power and no more proximal sensory loss.
- 02
Waiting for paralysis before recognising IIb, when even mild ischaemic weakness already requires emergency reperfusion.
- 03
Classifying a limb from arterial Doppler alone without recording venous signal, sensory distribution and active motor function.
- 04
Allowing an apparently reassuring capillary refill or normal early CK to overrule objective motor deficit.
- 05
Treating Rutherford I as routine outpatient PAD even though acute occlusion still needs urgent specialist assessment.
- 06
Attempting reperfusion of confirmed Rutherford III tissue without recognising severe systemic reperfusion risk.